Spots Global Cancer Trial Database for menorrhagia
Every month we try and update this database with for menorrhagia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) | NCT05538689 | Metrorrhagia Pelvic Pain Menorrhagia Leiomyoma | Myfembree Oral ... | 18 Years - | University of Chicago | |
Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | NCT00152256 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil Placebo | 18 Years - 53 Years | Abbott | |
Uterine Artery Occlusion for Fibroid Related Bleeding | NCT00496067 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | NCT01998854 | Menorrhagia Leiomyoma Uterine Fibroid... Uterine Fibroma Uterine Neoplas... | VizAblate Syste... | 28 Years - | Gynesonics | |
Fibroid Ablation Study | NCT01226290 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Syste... | 28 Years - | Gynesonics | |
Uterine Artery Occlusion for Fibroid Related Bleeding | NCT00496067 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
Directed Ablation of Uterine Fibroids Using a Noninvasive Approach | NCT03219385 | Uterine Leiomyo... | Mirabilis Syste... | 18 Years - 50 Years | Mirabilis Medica, Inc. | |
Minimally Invasive Benign Hysterectomy | NCT01865929 | Menorrhagia Metrorrhagia Uterine Fibroid... Cervical Dyspla... | Robotic hystere... Vaginal or lapa... | 25 Years - | Region Skane | |
Minimally Invasive Benign Hysterectomy | NCT01865929 | Menorrhagia Metrorrhagia Uterine Fibroid... Cervical Dyspla... | Robotic hystere... Vaginal or lapa... | 25 Years - | Region Skane | |
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy | NCT00755651 | Abnormal Uterin... | Endometrial bio... | 20 Years - 80 Years | Royal Free Hampstead NHS Trust | |
Fibroid Ablation Study | NCT01226290 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Syste... | 28 Years - | Gynesonics | |
Uterine Artery Embolization for Symptomatic Fibroids | NCT00354471 | Uterine Fibroid... Menorrhagia Adenomyosis | Uterine Artery ... | 18 Years - 60 Years | University of Manitoba | |
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
Hysteroscopic Monopolar and Bipolar Resection | NCT00323999 | Menorrhagia Fibroid Polyps | Hysteroscopic r... | 18 Years - 60 Years | Ullevaal University Hospital | |
Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
Surgical Success After Laparoscopic vs Abdominal Hysterectomy | NCT01793584 | Metrorrhagia Menorrhagia Leiomyoma Adenomyosis Pelvic Pain Endometriosis Pelvic Inflamma... | Laparoscopic hy... Abdominal hyste... | 18 Years - 80 Years | University of Texas Southwestern Medical Center | |
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology | NCT01969396 | Menorrhagia Endometrial Neo... Polycystic Ovar... Uterine Neoplas... | SonoBiopsy Cath... Endometrial bio... | 18 Years - | Cook Group Incorporated | |
Bone Mineral Density in Women With Uterine Fibroids or Endometriosis | NCT03744507 | Uterine Fibroid Endometriosis | 18 Years - 50 Years | Myovant Sciences GmbH | ||
Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding | NCT00496080 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids | NCT03070899 | Uterine Fibroid... Heavy Menstrual... | OBE2109 Placebo to matc... Placebo to matc... Add-back | 18 Years - | ObsEva SA | |
Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids | NCT00100191 | Menorrhagia Leiomyoma Uterine Neoplas... | uterine artery ... hysterectomy | 18 Years - | ZonMw: The Netherlands Organisation for Health Research and Development | |
Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding | NCT00496080 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids | NCT00277680 | Uterine Fibroid... | Laparoscopic bi... Radiological em... | 30 Years - | Oslo University Hospital | |
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions | NCT01750008 | Uterine Fibroid... Myomas | Global Fibroid ... Myomectomy | 18 Years - 55 Years | Acessa Health, Inc. | |
Hysteroscopic Monopolar and Bipolar Resection | NCT00323999 | Menorrhagia Fibroid Polyps | Hysteroscopic r... | 18 Years - 60 Years | Ullevaal University Hospital | |
Post Market TRUST Study | NCT01563783 | Uterine Fibroid... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
Study of Asoprisnil in the Treatment of Uterine Fibroids. | NCT00156156 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids | NCT03070951 | Uterine Fibroid... Heavy Menstrual... | OBE2109 Placebo to matc... Placebo to matc... Add-back | 18 Years - | ObsEva SA | |
Sonography Guided Transcervical Ablation of Uterine Fibroids | NCT02228174 | Menorrhagia | Intrauterine Ul... | 25 Years - 50 Years | Gynesonics | |
Minimally Invasive Benign Hysterectomy | NCT01865929 | Menorrhagia Metrorrhagia Uterine Fibroid... Cervical Dyspla... | Robotic hystere... Vaginal or lapa... | 25 Years - | Region Skane | |
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) | NCT05538689 | Metrorrhagia Pelvic Pain Menorrhagia Leiomyoma | Myfembree Oral ... | 18 Years - | University of Chicago | |
Directed Ablation of Uterine Fibroids Using a Noninvasive Approach | NCT03219385 | Uterine Leiomyo... | Mirabilis Syste... | 18 Years - 50 Years | Mirabilis Medica, Inc. | |
Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids | NCT00277680 | Uterine Fibroid... | Laparoscopic bi... Radiological em... | 30 Years - | Oslo University Hospital | |
Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution | NCT01581905 | Menorrhagia Dysfunctional U... Leiomyoma Pelvic Pain Endometriosis | Conventional La... Robot Assisted ... | 18 Years - 80 Years | Milton S. Hershey Medical Center | |
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study | NCT00768742 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Intra... | 25 Years - | Gynesonics | |
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study | NCT00768742 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Intra... | 25 Years - | Gynesonics | |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | NCT00160381 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil Placebo | 18 Years - | Abbott |